Guardant Health
GH
#2453
Rank
NZ$9.34 B
Marketcap
$75.68
Share price
-0.46%
Change (1 day)
173.05%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -$8.07

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -$8.26. In 2022 the company made an earnings per share (EPS) of -$10.77 a decrease over its 2021 EPS that were of -$6.73.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$8.07-25.07%
2022-$10.7760%
2021-$6.7355.04%
2020-$4.34207.14%
2019-$1.41-19.81%
2018-$1.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$8.11-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.20-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA